BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16225988)

  • 1. Roles of FHIT and WWOX fragile genes in cancer.
    Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
    Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.
    Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW
    Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large common fragile site genes and cancer.
    Smith DI; McAvoy S; Zhu Y; Perez DS
    Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
    Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
    Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the FHIT/FRA3B locus in cancer.
    Huebner K; Garrison PN; Barnes LD; Croce CM
    Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
    Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
    Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers.
    Karras JR; Schrock MS; Batar B; Huebner K
    Cytogenet Genome Res; 2016; 150(3-4):208-216. PubMed ID: 28199992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
    Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common fragile genes and digestive tract cancers.
    Kuroki T; Tajima Y; Furui J; Kanematsu T
    Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the common fragile site FRA3B does not affect FHIT expression.
    Michael D; Rajewsky MF
    Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.